Active Ingredient(s): Brexanolone
FDA Approved: * March 19, 2019

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Zulresso Overview

Allopregnanolone, also known as brexanolone, is a naturally produced steroid that acts on the brain.[9][10] As a medication, it is sold under the brand name Zulresso[6][11] and used to treat postpartum depression.[10][12][13] It is used by injection into a vein over a 60-hour period under medical supervision.[10][6] Side effects of brexanolone may inc...

Read more Zulresso Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Allopregnanolone

Recent Zulresso Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 5mg/ml
  • Solution: 100mg/20ml (5mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zulresso: (1 result)

Sorted by National Drug Code
  • 72152-547 Zulresso 5 mg/ml Intravenous Injection, Solution by Sage Therapeutics, Inc.

Other drugs which contain Brexanolone or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 7 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA